MEI Pharma

MEI Pharma Company(NASDAQ: MEIP)

Índice de influencia39

Proyectos similares

*Si no se puede hacer clic, significa que no hay información detallada disponible.

OSL Group

Investment holding company(0863.HK)

Bitcoin Group SE

Acquisition Portfolio Companies (ADE.DE)

Ming Shing Group

Wet trades works services company(NAQ: MSW)

Anap Holdings Inc.

Japanese apparel retailer(3189.T)

SenseTime Group Limited

AI Technology Company (HKEX: 0020.HK)

Convano Inc

Nail art operation listed company (TSE: 6574.T)

The Smarter Web Company

Web Design Digital Marketing Services（AQUIS: SWC）

瑞和数智

data intelligence and marketing technology enterprise(03680.HK)

Acerca de MEI Pharma

Fundado

2018

Comunidad

Etiquetas

Publicly listed company

Crypto Stocks

MEI Pharma, Inc.(NASDAQ: MEIP) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Detalles de la recaudación de fondos

Ronda de financiación	Cantidad	Valuación	Date	Inversores
Post-IPO	€85.90M	--	2025-07-21	--